🔎 Trials Near Me

Hem › Blodcancer › Illinois

Kliniska studier för Blodcancer i Illinois

16 studier för Blodcancer söker deltagare vid platser i Illinois.

Städer i Illinois

Officiell studietext (engelska)

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

  • The University of Chicago ( Site 0020), Chicago
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT03486873

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • OSF Saint Anthony's Health Center, Alton
  • Rush-Copley Medical Center, Aurora
  • Advocate Outpatient Center - Aurora, Aurora
  • och 54 fler
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

  • OSF Saint Anthony's Health Center, Alton
  • Rush-Copley Medical Center, Aurora
  • Advocate Outpatient Center - Aurora, Aurora
  • och 49 fler
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 17 sep. 2026 · NCT04242095

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

  • City of Hope - Chicago, Zion
RekryterarFas 1/2
Ålder 12 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT04588922

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
  • Loyola University Medical Center, Maywood
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 20 aug. 2026 · NCT06001788

Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer

  • Tempus AI, Chicago
RekryterarObservationsstudieFriska volontärer välkomna
Alla åldrar · Alla kön · Uppdaterad 10 aug. 2026 · NCT07756034

Mosaic Trial for Stem Cell Transplant Recipients

  • Northwestern University Feinberg School of Medicine, Chicago
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 3 aug. 2026 · NCT06960993

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Northwestern Memorial Hospital, Chicago
  • Rush University Medical Center, Chicago
  • University of Illinois at Chicago, Chicago
  • och 3 fler
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 6 juli 2026 · NCT01351545

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

  • Northwestern University, Chicago
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 11 juni 2026 · NCT06401356

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

  • University of Chicago, Chicago
RekryterarFas 1
Ålder 13 och äldre · Alla kön · Uppdaterad 5 maj 2026 · NCT04771572

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • Northwestern Memorial Hospital, Chicago
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 16 apr. 2026 · NCT03328078

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
  • Loyola University Medical Center, Maywood
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 13 mars 2026 · NCT05735184

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

  • University of Chicago Comprehensive Cancer Center, Chicago
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 20 feb. 2026 · NCT05745285

Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment

  • Northwestern University - Feinberg School of Medicine, Chicago
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 11 feb. 2026 · NCT07036133

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

  • MPN Research Foundation, Chicago
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 23 jan. 2026 · NCT07362225

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RekryterarFas 1
Ålder 1 till 21 · Alla kön · Uppdaterad 6 dec. 2024 · NCT05476770

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.